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241 Totally implantable venous access devices (TIVAD), a survey at
the Gothenburg CF-centre
G. Haugen1, K. Strandner2, M. Hufnagl2, A. Lindblad1, M. Gilljam2. 1Gothenburg
CF Centre, Sahlgrenska University Hospital, Queen Silvia Childrens Hospital,
Gothenburg, Sweden; 2Gothenburg CF Centre, Sahlgrenska University Hospital,
Respiratory Medicine, Gothenburg, Sweden
Objective: TIVAD has been used for many years at our CF centre for administration
intravenously at home of antibiotics and nutritional solutions. The CF-team give
individual information to the patient in need of a TIVAD, which is inserted in local
or general anaesthesia. The device is inspected regularly and ﬂushed with normal
saline and heparin every one to three months. We avoid to use it for blood samples.
We assessed the outcome of TIVADs; reasons for insertion, removal, lasting time
and complications.
Methods: Demographic and clinical data were extracted from the patient database
and patient charts. There were 175 patients [53 (30%) <18 years] with a median
age of 23 years (range 0−63) attending the Gothenburg CF-centre during 2013.
Lung-transplanted patients (11/175) were excluded from analysis.
Results: In total 49 patients (30% of the patient population) − 37 (33%) of the
adults and 12 (23%) of the children − had or had previously had a TIVAD and
32 (65%) were females. The total number of TIVADs was 80 (1−5/patient) with a
median time lasting of 4.8 (0.1–23.9) years by 31.12.2013. The ﬁrst TIVAD was
inserted at median of 12.5 years of age (range 0.5–38.6) and the major indication
was repeated intravenous antibiotic treatments.
Reasons for removal/change were infection, occlusion, venous thrombosis, catheter
fracture, local trauma or local reaction, patient’s wish or no more need of the device.
Three patients with thrombotic complications have new devices and anticoagulant
therapy.
Conclusion: TIVAD is a good and safe alternative for patients in need of frequent
infusions. Complications occur and have to be checked for regularly by the CF
nurse.
242 In-house provision of a PICC/Midline service by the CF nursing
team
D. Williams1, J. Robinson1, K. Bateman1, N.J. Bell1. 1Bristol Adult Cystic Fibrosis
Centre, Bristol, United Kingdom
Bristol Adult CF Centre (BACFC) is a CF specialist centre caring for ~200
patients in South West UK, delivering over 5600 days of intravenous antibiotic
therapy per year. For patients without totally implanted venous access devices,
midlines or peripherally inserted central venous catheters (PICCs) inserted under
ultrasound guidance offer greater comfort, reduced risk of infection, enhanced vein
preservation, easier patient to management and drug administration, and far greater
longevity than standard intravenous cannulas. However, midline/PICC insertion
under ultrasound guidance requires speciﬁc training.
The use of PICC/midlines has almost doubled in the last 2 years (Table 1) with
increasing number of IV days and high levels of patient satisfaction with the hospital
nurse-delivered service. Increased demand has increased pressure on the hospital
service, reducing ﬂexibility of start time and leading to delays inserting lines and
starting antibiotics.
Table 1
Midlines inserted PICCs inserted
September 2011 − August 2012 49 0
September 2012 − August 2013 83 5
To address this increase in demand a CF specialist nurse was trained to insert
midlines and PICCs under ultrasound guidance. Training comprised one mandatory
study day followed by 1 day a week for 6 months working alongside the hospital
PICC service nurses. The CF centre purchased an ultrasound machine at a cost of
GBP19000. Placement of 1 line per week is required to maintain skills.
Initial experience has been that the introduction of this in house service has
increased ﬂexibility and reduced waiting time for line insertion and initiation of
treatment.
243 Home visits of CF coordinating nurses − experience of Necker
hospital
M. Clairicia1, A. Lustre2, C. Bailly3, F. Chedevergne3, J. de Blic3,
M. Le Bourgeois3, I. Sermet-Gaudelus3. 1Hoˆpital Necker Enfants Malades,
CF Center, Paris, France; 2Hoˆpital Necker Enfants Malades, CRCM, Paris,
France; 3Hoˆpital Necker Enfants Malades, Paris, France
Objectives: 250 patients are followed in the Necker pediatric centre by 2 coordi-
nating nurses.
Methods: In order to personalize CF care, the CF nurses make home visits.
Results: We reviewed 71 home visits the last 2 years. 7 (4/3) were done to
explain CF care to parents of newly diagnosed children. These visits focussed on
hygiene procedures implementation, nutrition advices and beginning of therapeutic
education. 11 (5/6) visits were done for implementation of antibiotic nebulization,
the aim was to show the technics and the cleaning of the nebulizer. 20 (7/13) visits
were perfomed for IV infusion. Sometimes the parents were trained for IV infusion;
they had followed training courses at hospital before the coordinating nurse visited
the parents for the ﬁrst infusion. Home visits were more often dedicated for home
nurse training. 1 visit was perfomed last year for enteral nutrition implementation
in order to evaluate the technics at home. In this case it was the child who practised.
The other visits were done at school in order to facilitate school integration and a
few ones in other medical sites to exchange with the team.
Conclusion: Such visits enable enable the CF nursing staff to better understand the
daily reality of the family and adapt the CF care.
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E.J. Hunstad1, E. Bakkeheim2, M. Gilljam3. 1Oslo University Hospital, Norwegian
Resource Centre for Cystic Fibrosis, Oslo, Norway; 2The Norwegian Center for
Cystic Fibrosis, Oslo, Norway; 3Gothenburg CF Centre, Sahlgrenska University
Hospital, Gothenburg, Norway
Objectives: Infection control is a cornerstone in cystic ﬁbrosis (CF) care. Reducing
the risk of cross infection among hospitalised CF patients requires health care
professionals to sustain the awareness of CF guidelines. The aim of this study was
to illuminate awareness of hygiene regimens and infection control guidelines for
CF care at Scandinavian Cystic Fibrosis Centres (SCFCs) and Norwegian Cystic
Fibrosis Satellite Teams (NCFSTs).
Methods: We modiﬁed the knowledge, attitudes and practices (KAP) survey used
earlier for CF and Infection Control care teams in the United States regarding
sputum cultures, hand hygiene, education and infection control measures in hospital
or at home. Team professionals representing different disciplines at 6 SCFCs and
core team professionals at 10 NCFSTs received individual questionnaires.
Results: The response rate was 61/166 (37%) and 30/52 (58%) at the SCFCs
and NCFSTs respectively. SCFC respondents demonstrated higher KAP (range
49–100%) than NCFST (range 23–100%). Both groups had a high awareness of
outcome expectancy for selected guideline components (80–100%), but moderate
familiarity awareness. Items connected closely to practical care and medical treat-
ment had a KAP of 73% and 80% versus 93% and 74% respectively. There was
a low awareness 49% versus 23% of guideline contents for both groups, whereas
awareness above 75% for guideline components is commonly considered sufﬁcient.
Conclusion: This study revealed in general good KAP of CF infection control
measures in SCFC and NCFST, but there is nevertheless room for improvement of
CF guidelines components.
